FDA 483 - Kathleen N. Moore, M.D. - March 17, 2023

Kathleen N. Moore, M.D., a clinical investigator in Oklahoma City, was cited for failing to conduct an investigation in accordance with the signed statement of investigator and investigational plan. Specifically, the firm did not record all adverse events experienced by subjects during a clinical study, indicating a lapse in patient safety monitoring and protocol adherence.